AlphaCentric Advisors’s Pacira BioSciences PCRX Stock Holding History

AlphaCentric Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$3.36M	Hold
2024 Q1	$3.43M	Hold
2023 Q4	$3.96M	Buy
2023 Q3	$3.16M	Buy
2023 Q2	$2.26M	Buy
2023 Q1	$1.47M	Buy
2022 Q4	$734K	Buy